Distributed Access to Critical Biotherapeutics for Warfighters

Abstract

The goal of the Distributed Access to Critical Biotherapeutics for Warfighters program is to ensure DoD access to critical medical countermeasures (MCMs) by establishing the foundational technologies needed for fully distributable, on-demand manufacturing of protein-based medical countermeasures. To achieve this, investments will be made in technologies that enable immediate synthesis of bioactive protein MCMs at large yields. This technology will allow the DoD to scale up and scale out MCM production on an immediate time scale, securing access to both protein and nucleic acid based MCMs without reliance on complex supply chains or slow development cycles.

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2022
Source ID
005241e0ba81f610971b8b049d06a1aa

Tags

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Cybersecurity.
  • Molecular and Cellular Biochemistry

Technology Areas

  • Biotechnology

Related Documents